Neurocognitive disorders 2017 is mainly focused on the new scientific and technical advances in the field of Neurology and Neurocognitive disorders.
Online PR News – 13-May-2017 – London – ConferenceseriesLLC invites all the participants from all over the world to attend the prestigious conference entitled 16th International conference on Neurology and Neurocognitive disorders 2017 Scheduled to be held in between Oct 09-10 at London.
Neurology is a branch of medicine dealing with disorders of the nervous system. Neurology deals with the diagnosis and treatment of all categories of conditions and disease involving the central and peripheral nervous system (and its subdivisions, the autonomic nervous system and the somatic nervous system); including their coverings, blood vessels, and all effector tissue, such as muscle. Neurological practice relies heavily on the field of neuroscience, which is the scientific study of the nervous system.
Neurocognitive disorders are a group of conditions that frequently lead to impaired mental function Neurocognitive disorders most commonly occur in older adults, but they can affect younger people as well. Reduced mental function may include: problems with memory, changes in behaviour, difficulty understanding language, and trouble performing daily activities
These symptoms may be caused by a neurodegenerative condition, such as Alzheimer’s disease or dementia. Neurodegenerative diseases cause the brain and nerves to deteriorate over time, resulting in a gradual loss of neurological function. Neurocognitive disorders can also develop as a result of brain trauma or substance abuse. Healthcare providers can usually determine the underlying cause of neurocognitive disorders based on the reported symptoms and the results of diagnostic tests. The cause and severity of neurocognitive disorders can help healthcare providers determine the best course of treatment.
Neurocognitive disorders 2017 will provide a Forum for exchange of Ideas and Authoritative views by leading Scientists as well as Business leaders and Investors in this exciting field. Outstanding Keynote speakers and well known leading Scientists and experts from across the globe will be expected to share their knowledge. It is a broad audience gathering for exploring various neurocognitive disorders and their prevention and treatments.
Alzheimer’s disease is the most common form of dementia accounting for 50% to 70% of all cases. It mostly occurs in the older people who are 65 years and above. Moreover, growing awareness level regarding its symptoms, such as partial dementia, is projected to boost the demand. Currently, there are an estimated 4 million individuals with dementia in the USA with more than 100 000 deaths annually .The global market for Alzheimer’s disease reached $10.2 billion in 2012. The market is expected to decrease to $9.5 billion in 2017 for a CAGR of -1.5%.
The Alzheimer's Association funds independent investigators worldwide, they have awarded over $335 million to more than 2,250 projects. The global cost of Alzheimer’s and dementia is estimated to be $605 billion, which is equivalent to 1% of the entire world’s gross domestic product.
Aggregate Cost of Care by Payer for Americans Age 65 and Older with Alzheimer‘s Disease and Other Dementias: Medicare $113 Billion, Medicaid $41 Billion, Out of pocket $44 Billion, Other $29 Billion.
Dementia is widely considered the second most common cause of dementia after Alzheimer's disease, accounting for 10 percent of cases. Many experts believe that vascular dementia remains underdiagnosed like Alzheimer's disease even though it's recognized as common. The global market for treatments for syndromes of dementia and movement disorders was valued at 10.5 billion in 2011 and should reach $11.1 billion in 2012. Total market value is expected to reach $16.7 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8.5%.
ConferenceseriesLLC with its 2000+ employees has been supported by 50000+ well-qualified scientists as editorial board members who serve on voluntary basis to disseminate healthcare and scientific information open access, and year on year this support is increasing progressively with which Conferenceseries is able to grow from 10 peer reviewed journals in 2009 to 700 peer reviewed journals by 2016. ConfernceseriesLLC open access journals and conferences readers/online visitors also increased from 10,000 in 2009 to 30 million by 2016. OMICS International Conference Series organizes 3000 scientific meetings every year across America, Europe, Middle East and Asia.